Which action most directly reduces a patient’s risk of adverse drug reactions over time?

• A. Ongoing education of patients about their allergies and ADRs
• B. Only initial documentation
• C. Disabling allergy alerts
• D. Using the same drug class every time

Answer: (A)

Continuous patient education about allergies and adverse drug reactions keeps safety active as medications change. When patients understand what counts as an ADR, how to recognize early signs, and why certain drugs should be avoided, they’re more likely to report reactions promptly, ask questions, and avoid unsafe prescriptions. This ongoing knowledge helps keep allergy and ADR documentation current across all care encounters and guides clinicians to choose safer regimens or alternatives as needed. Relying on initial documentation can miss updates, new meds, or evolving allergies. Disabling allergy alerts removes a critical safety check that helps prevent inappropriate prescriptions. Reusing the same drug class every time misses opportunities to switch to safer options and can keep patients exposed to similar ADR risks. So, ongoing education directly supports safer decisions over time and reduces the likelihood of adverse drug reactions.